Crinetics Historical Cash Flow
| CRNX Stock | USD 31.11 1.91 5.78% |
Analysis of Crinetics Pharmaceuticals cash flow over time is an excellent tool to project Crinetics Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 220.1 M or Stock Based Compensation of 72.9 M as it is a great indicator of Crinetics Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Crinetics Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Crinetics Pharmaceuticals is a good buy for the upcoming year.
Crinetics | Build AI portfolio with Crinetics Stock |
About Crinetics Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Crinetics balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Crinetics's non-liquid assets can be easily converted into cash.
Crinetics Pharmaceuticals Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Crinetics Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Crinetics Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Crinetics Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Crinetics Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Crinetics Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Crinetics Stock please use our How to Invest in Crinetics Pharmaceuticals guide.At this time, Crinetics Pharmaceuticals' Change To Liabilities is fairly stable compared to the past year. Cash And Cash Equivalents Changes is likely to rise to about 63.7 M in 2025, despite the fact that Investments are likely to grow to (546.1 M).
| 2021 | 2022 | 2024 | 2025 (projected) | Change To Liabilities | 6.3M | 19.3M | 22.2M | 23.3M | Change To Netincome | 17.0M | 29.1M | 33.5M | 35.2M |
Crinetics Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Crinetics Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Crinetics Pharmaceuticals cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | 217K | (56.5M) | (174.0M) | (200.4M) | (574.8M) | (546.1M) | |
| Change In Cash | 52.8M | 107.6M | (167.2M) | 22.2M | 209.6M | 220.1M | |
| Stock Based Compensation | 10.4M | 17.4M | 28.3M | 40.9M | 69.4M | 72.9M | |
| Free Cash Flow | (62.2M) | (89.0M) | (116.9M) | (171.0M) | (229.8M) | (218.3M) | |
| Change In Working Capital | 376K | 1.1M | 18.6M | 8.0M | 11.6M | 12.2M | |
| Begin Period Cash Flow | 40.8M | 93.6M | 201.2M | 34.0M | 56.2M | 63.0M | |
| Total Cashflows From Investing Activities | 217K | (56.5M) | (174.0M) | (200.4M) | (574.8M) | (546.1M) | |
| Other Cashflows From Financing Activities | 288K | 3.1M | 4.7M | 19.9M | 40.4M | 42.4M | |
| Depreciation | 948K | 922K | 983K | 1.1M | 2.8M | 2.9M | |
| Other Non Cash Items | 261K | (739K) | 850K | 26.6M | (11.4M) | (10.8M) | |
| Capital Expenditures | 186K | 436K | 1.7M | 4.7M | 3.8M | 4.0M | |
| Total Cash From Operating Activities | (62.0M) | (88.6M) | (115.2M) | (166.3M) | (226.0M) | (214.7M) | |
| Change To Operating Activities | (2.8M) | (2.3M) | (5.2M) | (723K) | (650.7K) | (683.2K) | |
| Net Income | (73.8M) | (107.6M) | (163.9M) | (214.5M) | (298.4M) | (283.5M) | |
| Total Cash From Financing Activities | 114.6M | 252.7M | 122.0M | 388.9M | 1.0B | 1.1B | |
| End Period Cash Flow | 93.6M | 201.2M | 34.0M | 56.2M | 265.8M | 279.1M | |
| Change To Netincome | 6.3M | 10.5M | 17.0M | 29.1M | 33.5M | 35.2M | |
| Change To Liabilities | 696K | 2.7M | 6.3M | 19.3M | 22.2M | 23.3M | |
| Issuance Of Capital Stock | 114.3M | 249.5M | 117.2M | 369.0M | 970.0M | 1.0B | |
| Other Cashflows From Investing Activities | 227K | (422K) | (34K) | (195.7M) | 14.9M | 15.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Crinetics Stock Analysis
When running Crinetics Pharmaceuticals' price analysis, check to measure Crinetics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crinetics Pharmaceuticals is operating at the current time. Most of Crinetics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Crinetics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crinetics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Crinetics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.